We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




SNP Genotyping Platform Accurately Identifies Rare Donor Blood Types

By Labmedica staff writers
Posted on 10 Jul 2008
A single nucleotide polymorphism (SNP) genotyping platform enables faster screening for accurate identification of rare donor blood types. More...


There are many antigens located on the outer surface of the erythrocyte. Combinations of these blood group antigens vary between individuals even within the same A, B, or O blood type. The specificity of the antibodies in a recipient's blood and the prevalence of antigens in the donor population complicate the task of locating appropriate donors.

The OpenArray SNP genotyping platform, based on through-hole nanoliter fluidics technology, allows scientists to conduct up to 3,072 independent polymerase chain reaction (PCR) analyses simultaneously on a thin metal plate the size of a microscope slide. Developed by BioTrove (Woburn, MA, USA) the genotyping platform expands the capabilities of PCR.

BioTrove Inc. and BloodCenter of Wisconsin (Milwaukee, WI, USA) are collaborating to develop single SNP genotyping as a screening tool for identification of better-matched blood for transfusion. They will use the BioTrove OpenArray system to conduct erythrocyte genotyping more quickly and more economically. BloodCenter of Wisconsin will be able to stratify blood donors based on genotypic characteristics, improving the speed and accuracy of blood transfusions for patients in need.

BloodCenter's diagnostic laboratories develop and perform highly specialized tests on patient samples from throughout the United States and the world. The specialized testing and medical consultation provided by the diagnostic laboratories benefit patients in need of bone marrow or organ transplants, patients with bleeding and clotting disorders, and patients with immunologic, neoplastic, or genetic diseases.


Related Links:
BioTrove
BloodCenter of Wisconsin

Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Host Response Immunoassay Test
MeMed BV
New
Automated PCR Setup
ESTREAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.